How does the NPPA revision of ceiling prices of drugs aim to meet availability and affordability objectives
NPPA revises the ceiling prices of eight scheduled drugs to meet the twin objectives of availability and affordability.
- The NPPA revision of ceiling prices ensures that essential drugs are available to the public at reasonable prices.
- By periodically revising ceiling prices, NPPA prevents monopolistic pricing by pharmaceutical companies, thus enhancing affordability.
- Timely revisions help in curbing unreasonable price hikes, making medications more accessible to a wider population.
- Monitoring and regulating the prices of scheduled drugs encourage fair competition in the pharmaceutical industry, promoting accessibility and affordability.
- The revision aims to strike a balance between the interests of consumers and pharmaceutical companies, fostering a sustainable healthcare ecosystem.
Answered
6 months ago